The leading voice for decision-makers throughout the global biopharma ecosystem. Follow us on LinkedIn for exclusive insights & analysis: https://xitter.cf/t.co/V33Z1gfUfZ
Redwood City, Calif.
Joined December 2010
- Tweets39.8K
- Following1.8K
- Followers17K
- Likes4.1K
BioCentury retweeted
HHS has banned FDA, NIH, CDC employees from speaking to media, giving scientific talks, publishing public health reports. Pres Advisory Council on Combating Antibiotic-Resistant Bacteria mtg canceled. No word on FDA advisory comm mtgs.
biocentury.com/article/65479…
BioCentury retweeted
BioCentury invites you to attend its Grand Rounds event in Nashville this September to engage with thought leaders at the academia/industry interface. Register before August 2 to access the advanced discount. Learn more: bit.ly/3L16hsm
BioCentury retweeted
Grateful for excellent discussion w/ @PeaseRoland for @BBC @BBCWorld @bbcworldservice #ScienceInAction for the latest news on #H5N1 in the US.
Tune in soon for the premiere soon or catch online: bbc.co.uk/programmes/w3ct5vc…
@RickABright gave us a long interview for Science in Action addressing the inadequate govt response to the continued spread of H5N1 across US farms. "It's like PTSD from Feb/March 2020" he says of the testing regime.
2030 BST tonight, or podcast for more.
bbc.co.uk/programmes/w3ct5vc…
BioCentury retweeted
How WuXi AppTec is battling the Biosecure Act: @BioCentury's @SteveUsdin1 writes that the China CDMO continues to rebut assertions in anti-China biotech bills & says it can help revitalize U.S. biomanufacturing. @RepMoolenaar @RepAuchincloss
BioCentury retweeted
Following the #publication of our #obesity research last month, NodThera features in a new piece in @BioCentury, which explores the potential of #NLRP3 inhibitors to enhance CV benefits. For more: biocentury.com/article/65174…
#ICYMI #Pharma
BioCentury retweeted
We’ve partnered with @BioCentury for a webinar featuring an experienced panel of thought leaders, including Oppenheimer’s Michael Margolis.
Together, they will discuss the challenges confronting CEOs and the essential principles behind biotech growth in today's dynamic market.
BioCentury retweeted
6/ "The tough decisions are generally made right before it is too late." - @biogen CEO Chris Viehbacher in a fireside chat with @BioCentury CEO David Flores at the East-West Biopharma Summit in Boston/Cambridge Www.Biocenturyeastwest.com
BioCentury retweeted
2/ Great 1st day yesterday at East-West Summit including conference report keynote from @McKinsey on #AI and #biotech and 10-year @BioCentury BayHelix anniversary reception. Onsite registration starts today at 8am, Boston Marriott Cambridge. BioCenturyEastWest.com
BioCentury retweeted
Very pleased to be interviewed by Karen Tkach Tuzman as part of Nucleome’s Emerging Company Profile in @BioCentury.
You can read the full article here: biocentury.com/article/64895…
BioCentury retweeted
In response to Merck lawsuit, U.S. government rebuts Fifth and First Amendment challenges to IRA drug pricing program. Brief could be other pharma lawsuits. Also says Merck lacks standing. Merck's reply due by Oct. 19. ($) biocentury.com/article/64920…
BioCentury retweeted
This year, we have the chance to collaborate with @BioCentury ! All selected companies participating in @HTID_Paris are eligible for free trial access to BioCentury’s business intelligence platform!
Be part of HTID on October 24&25 2023 in Paris!
lnkd.in/eX_SA7Ha
BioCentury retweeted
Dear @CasperRuud98, when you play @DjokerNole you cannot take your eye off the ball for even one second. Never. @rolandgarros
BioCentury retweeted
Still time to RSVP (free) for @BioCentury "On the Road" networking event in Amsterdam, June 12 (week after #BIO2023).
Includes fireside chat with EMA's Emer Cooke moderated by my colleague @steveusdin1.
RSVP: on.lenos.com/biocentury/amst…
Hope to see you there! cc: @EMA_News
BioCentury retweeted
Many thanks to the CEOs, CFOs & VCs who joined our sold out 23rd #BioEquity in Dublin this week!
Next year @BioCentury & @EBDgroup will be in San Sebastian with a Regional Host Committee chaired by @YsiosCapital.
Register at BioEquityEurope.com. We hope to see you there!
BioCentury retweeted
Back from Dublin after another successful #BioEquity! It was to great to hear about the latest developments in the field and we are already looking forward to attending our next conference right here in Munich: Bio Europe in the fall.
BioCentury retweeted
We had a great time this week at the 23rd Bio€quity Europe Conference in Dublin, Ireland, organized by @BioCentury and @EBDgroup. See some pictures of the event below! #BioEquity
BioCentury retweeted
Biotech is entering the hard work phase of immuno-oncology - great conversation with @mmammen on precision medicine, the pharma to biotech transition, and more. The BioCentury Show, via @BioCentury. biocentury.com/article/64782…
BioCentury retweeted
ICYMI: @BioCentury's 23rd #BioEquity Europe has sold out.
➤ Please note digital passes remain (includes 2 days of virtual partnering with #biotech CEOs/VCs).
➤ You may also join the Wait List for in-person tickets.
Hope to see you there!
informaconnect.com/bioequity…
BioCentury retweeted
Influential thought leaders will be joining #AsiaBio. Register today and meet them in-person >> spr.ly/6019OHaDz
Karen Bernstein @BioCentury, Piers Ingram @hummingbirdbio, Vernessa Pollard @McDermottLaw, Siddhartha Sivaramakrishnan @McDermottLaw, Wei Wu @JNJInnovation
BioCentury retweeted
If you missed the @BioCentury & Putnam IRA Drug Pricing webinar last week, watch the recording here: BioCenturyIRA.com
Record attendance, record engagement, much debate.
Top takeaway: Investors are now hyper-focused on how biopharma management explains the IRA's impact.
